Paul Tredwell

Background

About Paul Tredwell

Paul Tredwell is the Executive Vice President (EVP) leading Accord in the EMENA region, one of the fastest growing pharmaceutical companies and a significant provider of medicines to healthcare systems across Europe. Responsible for all aspects of the organisation, including three manufacturing sites in Europe, all commercial operations spanning across 25 country offices, and partnerships totalling nearly 50 countries in the region. Over the past 5 years Paul has reshaped the specialty division of Accord through a combination of novel in house product and portfolio design, and an extremely dynamic Business Development team performing exceptional in licensing and M&A transactions. Paul has over 25 years industry experience, has launched nearly 30 speciality brands into European markets, from orphan to GP promoted brands, was the first person to fully commercialise a portfolio of biosimilars in a regulated market, performing the first NICE submission and approval for a biosimilar and establishing market access for this, at the time, new catalogory of medicines. He has launched countless generics over his tenure in some of the biggest speciality and generic companies in the world, making his experience unique. Paul is passionate about ‘making it better’ for patients designing, manufacturing or acquiring products that support patients and healthcare professionals with different options to standard of care including, augmeted delivery, duration of action and novel formulations, important at the time of need, while always ensuring patients have access to lifesaving medicines. A multiple award winner spanning 25 years in cutting edge digital technology, marketing, company growth awards to company of the year. Paul is passionate about pharmaceuticals and also passing his knowledge on to the growing team within Accord and beyond.